Clin Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Llorente, M. D.
Right arrow Articles by Urrutia, V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Llorente, M. D.
Right arrow Articles by Urrutia, V.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Diabetes 24:18-24, 2006
© American Diabetes Association ®, Inc., 2006

Feature Article

Diabetes, Psychiatric Disorders, and the Metabolic Effects of Antipsychotic Medications

Maria D. Llorente, MD and Victoria Urrutia, MD

IN BRIEF

Psychiatric disorders can be a risk factor for, as well as a complication of, diabetes. Antipsychotic medications, widely used to treat a variety of psychiatric conditions, are also associated with diabetes. This article explores the complex relationship among psychiatric disorders, antipsychotic medications, and risk factors for metabolic syndrome and diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.